These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9492839)

  • 21. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avascular necrosis of bone mimicking symmetric polyarthritis in a patient with malignant lymphoma treated with high-dose steroids.
    Buskila D; Thomson GT; Klein M; Keystone EC
    Isr J Med Sci; 1992 Nov; 28(11):804-5. PubMed ID: 1281809
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
    Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma.
    Terenghi F; Ardolino G; Nobile-Orazio E
    J Peripher Nerv Syst; 2007 Jun; 12(2):142-3. PubMed ID: 17565540
    [No Abstract]   [Full Text] [Related]  

  • 26. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
    Laurens A; Thevenot J; Charron D; Jorry F; Dumonchel P; Martola R
    Ann Med Interne (Paris); 1977 May; 128(5):493-6. PubMed ID: 334012
    [No Abstract]   [Full Text] [Related]  

  • 28. Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
    Kornacker M; Kraemer A; Leo E; Ho AD
    Ann Hematol; 2002 Feb; 81(2):103-5. PubMed ID: 11907791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of optimal CHOP dose ranges for elderly patients with non-Hodgkin's lymphoma].
    Mori M; Murai Y; Suzuki K; Nonaka Y; Sato H; Tomiyama J; Takagi T; Muto Y; Kashimura M
    Rinsho Ketsueki; 1999 Mar; 40(3):199-204. PubMed ID: 10222626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
    Mazzarotto R; Boso C; Vianello F; Aversa MS; Chiarion-Sileni V; Trentin L; Zambello R; Muzzio PC; Fiore D; Sotti G
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):823-9. PubMed ID: 17379431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphoma.
    Yamada T; Shinohara K; Takeda K; Kameda N; Katsuki K; Ariyoshi K; Kamei T
    Jpn J Clin Oncol; 1999 Apr; 29(4):226-8. PubMed ID: 10340048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vocal cord paralysis secondary to vincristine].
    Nafil H; Tazi I; Mahmal L
    Rev Neurol (Paris); 2012 May; 168(5):464-5. PubMed ID: 22387202
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy.
    Lossos IS; Ben-Yehuda D
    Ann Pharmacother; 1999 Feb; 33(2):253-4. PubMed ID: 10084428
    [No Abstract]   [Full Text] [Related]  

  • 37. Transverse nail ridgings (Beau's lines) induced by chemotherapy.
    Ben-Dayan D; Mittelman M; Floru S; Djaldetti M
    Acta Haematol; 1994; 91(2):89-90. PubMed ID: 7517608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
    Nielsen SH; Hasselbalch HC; Birgens HS
    Ugeskr Laeger; 1991 Oct; 153(42):2952-3. PubMed ID: 1949322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Picture in clinical hematology].
    Hatsuse M; Shimazaki C; Yumiba T
    Rinsho Ketsueki; 2013 Jan; 54(1):1. PubMed ID: 24015417
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of non-Hodgkin malignant lymphomas].
    Gociu M; Coliţă D; Leahu S; Ciocoiu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):1-10. PubMed ID: 6145200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.